Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring

Insights into new anticoagulants – a new thematic series in Thrombosis Journal

BioMed Central blog, 01 Jul 2013

For over 50 years now, vitamin K antagonists, such as warfarin, have been prescribed as anticoagulants for thrombotic disorders.